A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
/in Dendritic Cells, International Publications, Ovarian CancerTherapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsOncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusMelanoma immunotherapy using mature DCs expressing the constitutive proteasome
/in Dendritic Cells, International Publications, Malignant MelanomaRecombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease VirusActive immunotherapy using dendritic cells in the treatment of glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International PublicationsParenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics
/in International Publications, MicronutrientsA Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerBiochemical and immunologic markers in patients with metastatic melanoma treated with chemotherapy and dendritic cell vaccine.
/in Dendritic Cells, International Publications, Malignant Melanoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer